1. Up front

   Up front 20 September 2017 Pages: 2127 - 2128

   

2. Vascular complications in diabetes: old messages, new thoughts

   • Josephine M. Forbes
   • Amelia K. Fotheringham

   Review 19 July 2017 Pages: 2129 - 2138

   

3. Understanding and preventing type 1 diabetes through the unique working model of TrialNet

   • Manuela Battaglia
   • Mark S. Anderson
   • Mark Peakman

   Review Open access 02 August 2017 Pages: 2139 - 2147

   

4. Should we screen for type 2 diabetes among asymptomatic individuals? Yes

   • David Simmons
   • Janice C. Zgibor

   Commentary 23 August 2017 Pages: 2148 - 2152

   

5. Does the evidence support population-wide screening for type 2 diabetes? No

   • Jonathan E. Shaw

   Commentary 23 August 2017 Pages: 2153 - 2156

6. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial

   • Klemen Dovc
   • Maddalena Macedoni
   • Tadej Battelino

   Article Open access 24 August 2017 Pages: 2157 - 2167

   

7. Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement

   • Timothy J. McDonald
   • Rachel E. Besser
   • Andrew T. Hattersley

   Article Open access 05 August 2017 Pages: 2168 - 2173

   

8. Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

   • Antonio Eleuteri
   • Anthony C. Fisher
   • for the Individualised Screening for Diabetic Retinopathy (ISDR) Study Group

   Article Open access 24 August 2017 Pages: 2174 - 2182

   

9. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults

   • Rebecca K. Simmons
   • Simon J. Griffin
   • Annelli Sandbæk

   Article Open access 23 August 2017 Pages: 2183 - 2191

   

10. Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009

    • Rebecca K. Simmons
    • Simon J. Griffin
    • Annelli Sandbæk

    Article Open access 23 August 2017 Pages: 2192 - 2199

    

11. Screening for type 2 diabetes: do screen-detected cases fare better?

    • Adina L. Feldman
    • Simon J. Griffin
    • Olov Rolandsson

    Article Open access 23 August 2017 Pages: 2200 - 2209

    

12. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study

    • Lin Xu
    • Maria Carolina Borges
    • Debbie A. Lawlor

    Article Open access 09 September 2017 Pages: 2210 - 2220

    

13. Perceived racism and incident diabetes in the Black Women’s Health Study

    • Kathryn L. Bacon
    • Sherri O. Stuver
    • Edward A. Ruiz-Narváez

    Short Communication 15 August 2017 Pages: 2221 - 2225

14. Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents

    • Alon Peled
    • Barak Gordon
    • Arnon Afek

    Short Communication 19 August 2017 Pages: 2226 - 2230

15. Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes

    • Adem Y. Dawed
    • Ashfaq Ali
    • Paul W. Franks

    Article Open access 25 August 2017 Pages: 2231 - 2239

    

16. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion

    • Felicia Gerst
    • Robert Wagner
    • Dorothea Siegel-Axel

    Article 08 August 2017 Pages: 2240 - 2251

    

17. Relapsing/remitting type 1 diabetes

    • Kayleigh M. van Megen
    • Matthew P. Spindler
    • Bart O. Roep

    Short Communication Open access 23 August 2017 Pages: 2252 - 2255

    

18. The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse

    • Danielle J. Borg
    • Ran Wang
    • Sumaira Z. Hasnain

    Article Open access 04 August 2017 Pages: 2256 - 2261

    

19. VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells

    • Gaia Botteri
    • Marta Montori
    • Manuel Vázquez-Carrera

    Article 23 August 2017 Pages: 2262 - 2273

    

20. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes

    • Thomas Laeger
    • Christian Baumeier
    • Annette Schürmann

    Article Open access 02 August 2017 Pages: 2274 - 2284

    

21. Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes

    • Cristina Hernández
    • Patricia Bogdanov
    • Rafael Simó

    Article 04 August 2017 Pages: 2285 - 2298

    

22. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor

    • Abigail C. Lay
    • Jenny A. Hurcombe
    • Richard J. M. Coward

    Article Open access 29 August 2017 Pages: 2299 - 2311

    

23. Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy

    • Chinmay S. Marathe
    • Christopher K. Rayner
    • Michael Horowitz

    Letter 12 August 2017 Pages: 2312 - 2313

24. Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Reply to Marathe CS, Rayner CK, Jones KL, et al [letter]

    • Adam D. Farmer
    • Anne Grave Pedersen
    • Christina Brock

    Letter 17 September 2017 Pages: 2314 - 2315